RU-302

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRU-302
Drug Alias NameRU-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTYRO3 protein tyrosine kinase inhibitorsAXL receptor tyrosine kinase inhibitors
TargetsTYRO3 protein tyrosine kinaseAXL receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesRutgers University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A